You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

02-120

Showing 1 - 25 of 8,841
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overweight or Obesity Trial in Linköping, Uppsala (EMP16-02 120 mg orlistat/40 mg acarbose, EMP16-02 150 mg orlistat/50 mg

Completed
  • Overweight or Obesity
  • EMP16-02 120 mg orlistat/40 mg acarbose
  • +2 more
  • Linköping, Sweden
  • +1 more
Apr 1, 2022

HIV Trial (GEO-D02 DNA, MVA/HIV62B Vaccine, B63521^11 gp120)

Withdrawn
  • HIV Infections
  • GEO-D02 DNA
  • +4 more
  • (no location specified)
Oct 13, 2021

Advanced Solid Tumor Trial in Gdansk, Warsaw (RVU120)

Recruiting
  • Advanced Solid Tumor
  • Gdańsk, Poland
  • +1 more
Sep 24, 2021

Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome Trial in Poland, United States (RVU120(SEL120))

Recruiting
  • Acute Myeloid Leukemia
  • High-risk Myelodysplastic Syndrome
  • Miami, Florida
  • +6 more
Nov 5, 2021

HIV Trial in United States (Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A, NefTat, AS02A Adjuvant)

Completed
  • HIV Infections
  • Combination Vaccine (NefTat and gp120W61D) Formulated with AS02A
  • +3 more
  • Birmingham, Alabama
  • +14 more
Oct 13, 2021

Pancreatic Tumours, Midgut Neuroendocrine Tumours Trial in Worldwide (Lanreotide autogel 120 mg)

Completed
Has Results
  • Pancreatic Tumours
  • Midgut Neuroendocrine Tumours
  • Lanreotide autogel 120 mg
  • Bruxelles, Belgium
  • +31 more
Dec 4, 2020

Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

Completed
Has Results
  • Moderate to Severe Atopic Dermatitis
  • ISB 830 - Part 1 Group 1
  • +5 more
  • Birmingham, Alabama
  • +82 more
Jul 26, 2022

Overactive Bladder Trial in Worldwide (Placebo, BAY1817080)

Completed
  • Overactive Bladder
  • Botany, New South Wales, Australia
  • +27 more
Feb 9, 2022

Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)

Recruiting
  • Nucleophosmin 1-mutated Acute Myeloid Leukemia
  • Duarte, California
  • +60 more
Jul 20, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Stockton, California
  • +151 more
Sep 8, 2022

Bone Metastasis, Cancer Pain Trial in Worldwide (Tanezumab)

Completed
Has Results
  • Bone Metastasis
  • Cancer Pain
  • Rosario, Santa FE, Argentina
  • +88 more
Dec 21, 2022

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT 60 µg, RSV MAT 120 µg, Placebo)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSV MAT 60 µg
  • +2 more
  • Phoenix, Arizona
  • +31 more
Nov 12, 2021

Lymphoma Trial in Worldwide (Parsaclisib)

Active, not recruiting
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
Oct 14, 2022

Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

Active, not recruiting
  • Prurigo Nodularis
  • Nalbuphine ER Tablets
  • Matching Placebo Tablets
  • Phoenix, Arizona
  • +69 more
Jan 31, 2023

COVID-19 Trial in Beijing (HH-120 nasal spray, PartA cohort 1, HH-120 nasal spray, Part A cohort 2-7, HH-120 nasal spray, Part A

Active, not recruiting
  • COVID-19
  • HH-120 nasal spray, PartA cohort 1
  • +4 more
  • Beijing, Beijing, China
    Beijing TongRen Hospital, Capital Medical University
Feb 23, 2023

Hypercholesterolemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hypercholesterolemia
  • Evolocumab
  • +4 more
  • Birmingham, Alabama
  • +95 more
Jul 15, 2022

COVID-19, SARS-CoV-2 Infection Trial in Beijing (HH-120 Nasal Spray)

Completed
  • COVID-19
  • SARS-CoV-2 Infection
  • HH-120 Nasal Spray
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Feb 26, 2023

Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Medullary Thyroid Cancer
  • Medullary Thyroid Cancer
  • St Leonards, Australia
  • +33 more
Oct 20, 2021

Type 1 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Fresno, California
  • +80 more
Mar 1, 2022

SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)

Completed
  • SARS-CoV-2 Infection
  • HH-120 nasal spray 1
  • +3 more
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Mar 1, 2023

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Atopic Dermatitis Trial in Worldwide (Tralokinumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Brussels, Belgium
  • +73 more
Sep 27, 2021

Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
  • Sham Surgery
  • Birmingham, Alabama
  • +8 more
Nov 8, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Lymphoma, Mantle-Cell Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

Recruiting
  • Lymphoma, Mantle-Cell
  • Barretos, Brazil
  • +150 more
Jan 27, 2023